miR-21 can target phosphatase and tensin homolog, which are involved in hepatic steatosis prevention, and PPARα expression, which activates lipid oxidation and determines inflammation and fibrosis progression in NAFLD [28]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.